Targeted Strategies for Today's Evolving Markets

MissionIR Blog

IRIDEX Corp. (IRIX) Granted Major Patent to Assist in Eye Surgery

While IRIDEX was only founded in 1989, they have already established a reputation as a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems and delivery services. Today, IRIDEX took a major step towards prominence when they were granted a U.S. Patent for the Stepped Angle EndoProbe handpiece design which is utilized in eye surgery.

The patent, No. 7,909,816 is entitled “Directional Probe Treatment Apparatus.” This patent applies to a number of consumable medical devices already in the IRIDEX product line collectively known as Stepped Angled EndoProbe laser handpieces.

The patented Stepped Angled EndoProbe is a state-of-the-art handpiece that offers some unique advantages over alternative angled probes. For example, the handpieces are extremely durable and readily tolerate the rigors of invasive laser surgery, while simultaneously delivering laser energy that has less aberration with consistently lower divergence and higher irradiance.

Leading the way at IRIDEX is Theodore A. Boutacoff who serves as the company’s President and CEO. Commenting on what this patent will mean to the future of the young company, Boutacoff was quoted as saying, “This is an important patent for us because our Stepped Angled probes are the best selling product line within our consumable product portfolio. Users of these handpieces consistently comment on their performance, ease of use and their longer working distance compared to competitive probes. This patent helps us further differentiate our products from our competitors and creates new barriers for competition.”

To learn more about the company as a whole, visit their corporate website at:

Let us hear your thoughts below:

This entry was posted in Small Cap News. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *